MedTrace Logo

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars

NCT02968459 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2022-12-21

No results posted yet for this study

Summary

This is a single center, randomized, double blind, placebo controlled study to evaluate the safety and efficacy of umbilical cord mesenchymal stem cell local intramuscular injection for treatment of caesarean section uterine scars.

Conditions

  • Uterine Scar

Interventions

OTHER

Umbilical cord MSCs

Participants will receive direct local intramuscular injection of 1\*10\^7 MSCs (in 1ml of 0.9% saline) in the uterine incision.

OTHER

0.9% Saline

Participants will receive direct local intramuscular injection 1ml of 0.9% saline in the uterine incision.

Sponsors & Collaborators

  • Maternal and Child Health Hospital of Foshan

    lead OTHER

Principal Investigators

  • Zhengping Liu, MD · Maternal and Child Health Hospital of Foshan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-31
Primary Completion
2021-12-31
Completion
2022-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02968459 on ClinicalTrials.gov